Treat All
Showing 1 - 25 of >10,000
d to Treat All Types of Edentulism in Maxilla and Mandible
Completed
- Partial Edentulism
-
Graz, AustriaMedizinische Universitat Graz- Klinische Abteilung fur Zahnersat
Jul 11, 2022
Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)
Recruiting
- Acute Lymphoblastic Leukemia
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 2, 2023
Bone Cancer, Bone Tumor, Solid Tumor Trial in United States (153-Sm-DOTMP (Samarium-153-DOTMP))
Recruiting
- Bone Cancer
- +4 more
- 153-Sm-DOTMP (Samarium-153-DOTMP)
-
Chicago, Illinois
- +3 more
Aug 18, 2023
Breast Cancer Stage IV Trial in Iowa City, New Delhi, Chandigarh (Lutetium-177-PEG-avß3-IAC)
Not yet recruiting
- Breast Cancer Stage IV
-
Iowa City, Iowa
- +2 more
Jun 7, 2022
Invasive Ductal Breast Carcinoma, Invasive Ductal Breast Carcinoma Stage IV, Lobular Breast Carcinoma Trial in United States
Recruiting
- Invasive Ductal Breast Carcinoma
- +14 more
- Stereotactic body radiotherapy
- Lattice Radiation Therapy
-
Basking Ridge, New Jersey
- +6 more
Apr 20, 2023
Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)
Active, not recruiting
- Multiple Myeloma
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Mar 7, 2022
SARS-CoV-2 Infection Trial in India (Nitric Oxide)
Completed
- SARS-CoV-2 Infection
- Nitric Oxide
-
Aurangabad, India
- +20 more
Oct 27, 2022
Leukemia Trial in Beijing (IM19 CAR-T)
Unknown status
- Leukemia
- IM19 CAR-T
-
Beijing, Beijing, ChinaPeking University people's hospita
Dec 15, 2020
Cystic Fibrosis Trial in Canada, United States (Nitric Oxide 160 ppm)
Terminated
- Cystic Fibrosis
- Nitric Oxide 160 ppm
-
Garden Grove, California
- +6 more
Mar 3, 2021
Type 2 Diabetes Trial in Australia, China, United States (INS068 injection, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- INS068 injection
- Insulin Degludec
-
Huntington Park, California
- +32 more
Jan 27, 2022
Sepsis, Hemodynamic Instability, Bacterial Infections Trial in Singapore (Therapeutic Drug Monitoring (TDM))
Recruiting
- Sepsis
- +4 more
- Therapeutic Drug Monitoring (TDM)
-
Singapore, SingaporeSingapore General Hospital
Jul 17, 2023
Psoriatic Arthritis Trial in Norway (Imaging informed treat-to-target, Conventional treat-to-target)
Recruiting
- Psoriatic Arthritis
- Imaging informed treat-to-target
- Conventional treat-to-target
-
Bergen, Norway
- +11 more
Nov 23, 2022
Low Back Pain, Failed Back Surgery Syndrome, Neuropathic Pain Trial in Dordrecht (SubQ)
Completed
- Low Back Pain
- +2 more
- SubQ
-
Dordrecht, Zuid Holland, NetherlandsAlbert Schweitzer hospital
Jan 5, 2020
Neovascular Age-related Macular Degeneration Trial in Worldwide (brolucizumab)
Active, not recruiting
- Neovascular Age-related Macular Degeneration
-
Huntington Beach, California
- +59 more
Jan 20, 2023
Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,
Not yet recruiting
- Neovascular Age-related Macular Degeneration
- Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
- Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
- (no location specified)
Jun 6, 2023
Head Pain Trial in Monastir (Magnesium sulfate)
Recruiting
- Head Pain
- Magnesium sulfate
-
Monastir, TunisiaUniversity of Monasrtir
Feb 2, 2023
Functional Tricuspid Regurgitation Trial in Korea, Republic of (Pivot Bridge)
Recruiting
- Functional Tricuspid Regurgitation
- Pivot Bridge
-
Daegu, Dalseo-gu, Korea, Republic of
- +9 more
May 2, 2023
Maxillary Sinusitis Trial in Buraydah (Single-step Functional Sinus Endoscopy and Transoral Surgery, Functional sinus endoscopy,
Recruiting
- Maxillary Sinusitis
- Single-step Functional Sinus Endoscopy and Transoral Surgery
- +2 more
-
Buraydah, Qassim Province, Saudi ArabiaGhada Amin Khalifa
Nov 11, 2023
Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)
Approved for marketing
- Graft-versus-host Disease (GVHD)
- (no location specified)
Jan 26, 2023
Tildrakizumab in Difficult-to-treat Areas in Psoriasis
Recruiting
- Psoriasis Palmaris
- +4 more
- Psoriasis clinical assessments
- +3 more
-
Paris, FranceService de Dermatologie- Hopital Saint Joseph
Jul 3, 2023
ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)
Not yet recruiting
- ER-positive Breast Cancer
- +3 more
- Elacestrant
- +4 more
- (no location specified)
Aug 22, 2022